LIMITED STAGE SMALL CELL LUNG CANCER
Clinical trials for LIMITED STAGE SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LIMITED STAGE SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LIMITED STAGE SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested in aggressive lung cancer
Disease control Not yet recruitingThis study is testing whether adding a new immunotherapy drug called adebrelimab to standard chemotherapy and radiation can better control limited-stage small-cell lung cancer. It will enroll 30 patients to see if this combination is safe and effective at keeping the cancer from …
Matched conditions: LIMITED STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug aims to shield patients from Chemo's harsh side effects
Disease control Not yet recruitingThis study is testing whether a drug called trilaciclib can protect patients' bone marrow from damage during chemotherapy for a type of lung cancer. About 120 people with limited-stage small cell lung cancer will receive either trilaciclib or a placebo before their chemo. The mai…
Matched conditions: LIMITED STAGE SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Pharmacosmos A/S • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC